HomeFATE • NASDAQ
add
Fate Therapeutics Inc
Previous close
$1.33
Day range
$1.29 - $1.44
Year range
$1.04 - $8.83
Market cap
156.60M USD
Avg Volume
3.10M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 3.07M | 58.13% |
Operating expense | 20.80M | 9.78% |
Net income | -47.68M | -5.55% |
Net profit margin | -1.55K | 33.25% |
Earnings per share | -0.40 | 13.04% |
EBITDA | -47.77M | -2.65% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 296.92M | -15.10% |
Total assets | 494.97M | -8.98% |
Total liabilities | 132.64M | -5.93% |
Total equity | 362.33M | — |
Shares outstanding | 113.89M | — |
Price to book | 0.42 | — |
Return on assets | -25.58% | — |
Return on capital | -27.31% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -47.68M | -5.55% |
Cash from operations | -29.42M | 23.13% |
Cash from investing | 25.46M | 2.64% |
Cash from financing | 0.00 | — |
Net change in cash | -3.96M | 70.61% |
Free cash flow | -13.34M | 37.98% |
About
Founded
2007
Website
Employees
181
